Mayflower Financial Advisors, LLC Gsk PLC Transaction History

Mayflower Financial Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	BUY	$42.05 - $47.77 $1,345 - $1,528	32 Added 0.48%	6,744 $294,000
Q1 2022 Apr 21, 2022	BUY	$40.23 - $47.74 $1,810 - $2,148	45 Added 0.67%	6,712 $292,000
Q4 2021 Jan 21, 2022	BUY	$38.88 - $45.31 $10,769 - $12,550	277 Added 4.33%	6,667 $294,000
Q3 2021 Oct 26, 2021	BUY	$38.79 - $43.16 $1,629 - $1,812	42 Added 0.66%	6,390 $250,000
Q2 2021 Jul 29, 2021	SELL	$36.52 - $41.46 $31,881 - $36,194	-873 Reduced 12.09%	6,348 $253,000
Q1 2021 Apr 23, 2021	SELL	$34.27 - $40.01 $15,078 - $17,604	-440 Reduced 5.74%	7,221 $258,000
Q4 2020 Apr 12, 2021	BUY	$34.07 - $39.94 $261,010 - $305,980	7,661 New	7,661 $282,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Mayflower Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mayflower Financial Advisors, LLC with notifications on news.